Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$1.76M Buy
29,582
+776
+3% +$47.9K 0.02% 296
2016
Q2
$1.86M Sell
28,806
-3,805
-12% -$219K 0.02% 285
2016
Q1
$1.83M Sell
32,611
-2,193
-6% -$117K 0.02% 318
2015
Q4
$1.77M Sell
34,804
-5,988
-15% -$304K 0.02% 314
2015
Q3
$2.06M Buy
40,792
+19,588
+92% +$950K 0.03% 287
2015
Q2
$984K Hold
21,204
0.01% 381
2015
Q1
$1.12M Hold
21,204
0.02% 348
2014
Q4
$1.17M Buy
21,204
+6,188
+41% +$317K 0.02% 328
2014
Q3
$667K Hold
15,016
0.01% 427
2014
Q2
$771K Buy
+15,016
New +$755K 0.01% 353

Other funds holding ALE

Analytic Investors's ALE Position: Q3 2016 in Review

Analytic Investors increased its Allete (ALE) stake by 2.7% in Q3 2016, buying an estimated $47.9K and bringing the position to 29,582 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #296.

Analytic Investors first reported a position in ALE in Q2 2014 and has held it in 10 quarters since. The position peaked at $2.06M in Q3 2015. 252 funds tracked by Wall St. Rank hold ALE as of Q3 2016.

  • Analytic Investors held 29,582 shares of Allete worth $1.76M as of Q3 2016.
  • Analytic Investors bought 776 Allete shares in Q3 2016, an estimated $47.9K.
  • Allete made up 0.02% of Analytic Investors's portfolio in Q3 2016, its #296 holding.
  • Analytic Investors first reported a position in Allete in Q2 2014 and has held it in 10 quarters since.
  • Analytic Investors's Allete position peaked at $2.06M in Q3 2015.
  • 252 funds tracked by Wall St. Rank held Allete as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.